Why Bristol Myers Squibb is a Top 25 Dividend Giant (BMY)

Nov 19, 2024 · Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $15.01B worth of stock held by ETFs, and above-average ''DividendRank ...

$15.01
OFF

Why Bristol Myers Squibb Is A Top 25 Dividend Giant (BMY)

2 weeks from now

nasdaq.com

$15.01
OFF

Bristol Myers Squibb Named Top 25 Dividend Giant With $15.01B …

2 weeks from now

Nov 19, 2024 · Bristol Myers Squibb Co. (BMY) has been named a Top 25 "Dividend Giant" by ETF Channel due to its $15.01B worth of stock held by ETFs and above-average dividend …

ainvest.com

$15.01
OFF

Bristol Myers Squibb: Top Dividend Giant - BMY Stock

2 weeks from now

Nov 20, 2024 · Bristol Myers Squibb Co. (BMY) has been recognized as a Top 25 "Dividend Giant" by ETF Channel, with $15.01 billion in stock held by ETFs. The company's attractive …

investingsnacks.com

14%
OFF

Bristol-Myers Squibb (BMY) Stock Dividend History & Growth - 2025

2 weeks from now

BMY pays a solid dividend yield of 5.14%, which is higher than the average of the bottom 25% of dividend payers in the US market (0.490%). BMY’s dividend yield is lower than the average of …

stockinvest.us

$3.09
OFF

Why Bristol-Myers Squibb Is A Top 25 Dividend Giant (BMY)

2 weeks from now

Apr 3, 2014 · Bristol-Myers Squibb has been named as a Top 25 Dividend Giant by ETF Channel, with a staggering $3.09B worth of stock held by ETFs. Close Lightbox Download the free …

investorplace.com

$2
OFF

Bristol Myers A Top Socially Responsible Dividend Stock With 4

2 weeks from now

Dec 9, 2024 · The annualized dividend paid by Bristol Myers Squibb Co. is $2.4/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 10/04/2024

forbes.com

66%
OFF

Bristol Myers Squibb A Top 25 Dividend Giant With 3.66% Yield …

2 weeks from now

Bristol Myers Squibb Co. (NYSE:BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $0 worth of stock held by ETFs, and above-average …

preferredstockchannel.com

$3.56
OFF

Why Bristol-Myers Squibb Is A Top 25 Dividend Giant (BMY)

2 weeks from now

Nov 12, 2015 · Bristol-Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel , with a whopping $3.56B worth of stock held by.

nasdaq.com

$16.91
OFF

Why Bristol Myers Squibb Is A Top 25 Dividend Giant (BMY)

2 weeks from now

Jun 10, 2021 · Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $16.91B worth of stock held by ETFs, and above …

nasdaq.com

$3.49
OFF

Why Bristol-Myers Squibb Is A Top 25 Dividend Giant (BMY) - Forbes

2 weeks from now

May 7, 2015 · Bristol-Myers Squibb Co. (NYSE: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a stunning $3.49B worth of stock held by ETFs, and above …

forbes.com

$18.24
OFF

BMY A Top 25 Dividend Giant With $18.24B Held By ETFs - Nasdaq

2 weeks from now

Jun 13, 2023 · Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $18.24B worth of stock held by ETFs, and above …

nasdaq.com

6%
OFF

This Unpopular Dividend Stock Is A Buy | The Motley Fool

2 weeks from now

Jan 9, 2025 · Bristol-Myers Squibb's shares have declined 11.6% over the prior five years while the S&P 500 delivered total returns of 97.5%. The pharmaceutical giant offers a 4.34% yield …

fool.com

94%
OFF

Bristol Myers Squibb A Top 25 Dividend Giant With 2.94% Yield …

2 weeks from now

Jun 14, 2022 · Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a stunning $20.91B worth of stock held by ETFs, and above …

nasdaq.com

66%
OFF

Bristol Myers Squibb A Top 25 Dividend Giant With 3.66% Yield …

2 weeks from now

Dec 14, 2021 · Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $0 worth of stock held by ETFs, and above-average …

nasdaq.com

80%
OFF

Bristol-Myers Squibb A Top 25 Dividend Giant With 2.80% Yield …

2 weeks from now

Jun 29, 2017 · Bristol-Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel , with a whopping $8.07B worth of stock held by.

nasdaq.com

FAQs about Why Bristol Myers Squibb is a Top 25 Dividend Giant (BMY) Coupon?

Is Bristol Myers Squibb (BMY) a good dividend stock?

Bristol Myers Squibb (BMY) has a dividend yield of 4.66%, which is above the Healthcare sector, the industry, and its peers' average of 1.75%. The latest BMY stock dividend of $0.6 is an increase from the previous $0.57 distribution, representing a growth of 5%. ...

Is Bristol Myers Squibb a member of iShares USA ESG select ETF?

According to the ETF Finder at ETF Channel, Bristol Myers Squibb Co. is a member of the iShares USA ESG Select ETF (SUSA), making up 0.36% of the underlying holdings of the fund, which owns $17,970,815 worth of BMY shares. Top 25 Socially Responsible Dividend Stocks — Income To Feel Good About » ...

Is Bristol Myers Squibb a socially responsible dividend stock?

Bristol Myers Squibb has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 4.0% yield, as well as being recognized by prominent asset managers as being a socially responsible investment, through analysis of social and environmental criteria. ...

Does Bristol-Myers Squibb have a trailing dividend?

Bristol-Myers Squibb has a trailing dividend yield of 2.7% on the current share price of $78.96. ...

Does Bristol-Myers Squibb pay dividends?

Bristol-Myers Squibb pays quarterly dividends to shareholders. When was Bristol-Myers Squibb's most recent dividend payment? Bristol-Myers Squibb's most recent quarterly dividend payment of $0.60 per share was made to shareholders on Friday, November 1, 2024. ...

Should you buy Bristol-Myers Squibb (BMY)?

Like a champion boxer on the ropes, Bristol-Myers Squibb (BMY -1.73%) finds itself in a challenging position. Specifically, the pharmaceutical giant's shares have declined by a disappointing 11.6% over the prior five years while the benchmark S&P 500 has delivered total returns of 97.5%, including dividends. ^SPX data by YCharts. ...